Vanda Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. 

CEO
Mihael Hristos Polymeropoulos
CEOMihael Hristos Polymeropoulos
Employees
368
Employees368
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
2002
Founded2002
Employees
368
Employees368

VNDA Key Statistics

Market cap
281.41M
Market cap281.41M
Price-Earnings ratio
-6.42
Price-Earnings ratio-6.42
Dividend yield
Dividend yield
Average volume
523.05K
Average volume523.05K
High today
$4.92
High today$4.92
Low today
$4.77
Low today$4.77
Open price
$4.90
Open price$4.90
Volume
292.78K
Volume292.78K
52 Week high
$6.37
52 Week high$6.37
52 Week low
$3.81
52 Week low$3.81

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.